Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal Carcinoma

NCT00868192 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Carcinoma
Primary Peritoneal Carcinoma

Interventions

DRUG: Pemetrexed
DRUG: Bevacizumab

Sponsor

Washington University School of Medicine

Collaborators

[object Object]